Danilo Menichelli


Titolo Pubblicato in Anno
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients THROMBOSIS AND HAEMOSTASIS 2022
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 2022
Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease NUTRIENTS 2022
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry PLATELETS 2022
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry JOURNAL OF PERSONALIZED MEDICINE 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study THE LANCET 2022
Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis INTERNAL AND EMERGENCY MEDICINE 2022
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention THE AMERICAN JOURNAL OF CARDIOLOGY 2021
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study CANCER 2021
Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 2021
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a network metanalysis on 605,771 patients EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY 2021
Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants MAYO CLINIC PROCEEDINGS 2021
Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study MOLECULES 2021
Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment PROGRESS IN CARDIOVASCULAR DISEASES 2021
A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients FRONTIERS IN PHARMACOLOGY 2021
Use of direct oral anticoagulants in patients with antiphospholipid syndrome. a systematic review and comparison of the international guidelines FRONTIERS IN CARDIOVASCULAR MEDICINE 2021
Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. data from the athero-af study FRONTIERS IN CARDIOVASCULAR MEDICINE 2021
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes. insights from the START-ANTIPLATELET registry INTERNATIONAL JOURNAL OF CARDIOLOGY 2021
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. the nationwide PLECTRUM study BRITISH JOURNAL OF HAEMATOLOGY 2020
Seronegative antiphospholipid syndrome: Refining the value of “non-criteria” antibodies for diagnosis and clinical management HAEMATOLOGICA 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma